Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Padcev
Pharma
AZ’s Imfinzi gains ground on Keytruda in bladder cancer race
AZ's perioperative Imfinizi plus neoadjuvant Padcev met phase 3 goals in cisplatin-ineligible MIBC, teeing up a showdown with Merck's Keytruda.
Kevin Dunleavy
,
Angus Liu
May 14, 2026 11:52am
Pfizer's COVID franchise keeps guidance level after strong Q1
May 5, 2026 11:17am
Astellas projects Xtandi decline but overall growth in FY2026
Apr 27, 2026 11:30am
Kyowa, Sino Biopharm, Duality—Fierce Pharma Asia
Mar 6, 2026 9:35am
Padcev-Keytruda combo wins in MIBC amid evolving landscape
Feb 27, 2026 10:00am
Astellas lifts forecast as Vyloy surge counters trial miss
Feb 5, 2026 11:00am
